Free tool
FAERS Monitor: Seroquel Xr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022172 or its brand name (Seroquel Xr, Quetiapine Fumarate). Reports on generic versions are filed under their own applications.
Reports
166,283
Serious
129,383
78% of reports
Hospitalization
60,266
Death reported
22,401
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective9,887
- off label use9,865
- insomnia8,363
- toxicity to various agents8,318
- diabetes mellitus8,095
- somnolence7,358
- fatigue7,022
- drug interaction6,787
- weight increased6,710
- anxiety6,689
- nausea6,604
- depression6,467
- drug dose omission5,986
- completed suicide5,813
- dizziness5,718
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,549 |
| 2005 | 1,921 |
| 2006 | 3,134 |
| 2007 | 5,530 |
| 2008 | 3,326 |
| 2009 | 7,688 |
| 2010 | 9,164 |
| 2011 | 10,170 |
| 2012 | 10,999 |
| 2013 | 4,481 |
| 2014 | 5,545 |
| 2015 | 7,047 |
| 2016 | 6,970 |
| 2017 | 8,436 |
| 2018 | 9,760 |
| 2019 | 10,016 |
| 2020 | 10,161 |
| 2021 | 9,134 |
| 2022 | 8,643 |
| 2023 | 8,868 |
| 2024 | 8,920 |
| 2025 | 8,430 |
| 2026 | 6,387 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,887,876 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diabetes mellitusSignal | 8,095 | 14.9 | 14.6 | 94,208 |
| completed suicideSignal | 5,813 | 9.4 | 9.2 | 40,799 |
| toxicity to various agentsSignal | 8,318 | 6.5 | 6.4 | 37,177 |
| drug interactionSignal | 6,787 | 5.6 | 5.5 | 24,784 |
| somnolenceSignal | 7,358 | 4.8 | 4.7 | 21,252 |
| drug dose omissionSignal | 5,986 | 4.7 | 4.6 | 17,016 |
| insomniaSignal | 8,363 | 4.1 | 4.0 | 18,980 |
| weight increasedSignal | 6,710 | 3.9 | 3.8 | 14,038 |
| depressionSignal | 6,467 | 3.7 | 3.6 | 12,342 |
| anxietySignal | 6,689 | 3.0 | 2.9 | 8,947 |
| dizziness | 5,718 | 1.5 | 1.4 | 824 |
| off label use | 9,865 | 1.4 | 1.4 | 1,315 |
| fatigue | 7,022 | 1.1 | 1.1 | 128 |
| nausea | 6,604 | 1.1 | 1.0 | 20 |
| drug ineffective | 9,887 | 0.9 | 0.9 | 29 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.